<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/pf.v14i4.1767</article-id><article-id custom-type="elpub" pub-id-type="custom">ppharm-1544</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МНЕНИЕ ПО ПРОБЛЕМЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROBLEMS. EXPERT OPINION</subject></subj-group></article-categories><title-group><article-title>Мнение инфекциониста</article-title><trans-title-group xml:lang="en"><trans-title>The Infectiologist’s Point of View</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7222-6760</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilyina</surname><given-names>Svetlana V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, заведующая кафедрой детских инфекционных болезней Иркутского государственного медицинского университета</p><p>Адрес: 664003, Иркутск, ул. Красного восстания, д. 1, тел.: +7 (3952) 24-38-25</p></bio><email xlink:type="simple">dr_ilina@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Иркутский государственный медицинский университет<country>Россия</country></aff><aff xml:lang="en">Irkutsk State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>05</day><month>10</month><year>2017</year></pub-date><volume>14</volume><issue>4</issue><fpage>314</fpage><lpage>315</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ильина С.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Ильина С.В.</copyright-holder><copyright-holder xml:lang="en">Ilyina S.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/1544">https://www.pedpharma.ru/jour/article/view/1544</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;(6):CD001266. doi: 10.1002/14651858.CD001266.pub4.</mixed-citation><mixed-citation xml:lang="en">Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;(6):CD001266. doi: 10.1002/14651858.CD001266.pub4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
